Novel nanoparticle vaccines for Listeriosis

References

• Frande-Cabanes E, Fernandez-Prieto L, Calderon-Gonzalez R, Rodríguez-Del Río E, Yañez-Diaz S, Fanarraga ML, Alvarez-Dominguez C. Dissociation of Innate Immune Responses in Microglia Infected with Listeria monocytogenes. Glia 2014; 62:233-46; PMID:24311463; http://dx.doi.org/10.1002/glia.22602
   PubMed Web of Science ®Google Scholar
• Pérez Trallero E, Zigorraga C, Artieda J, Alkorta M, Marimón JM. Two outbreaks of Listeria monocytogenes infection, Northern Spain. Emerg Infect Dis 2014; 20(12):2155-7; http://dx.doi.org/10.3201/eid2012.140993
   PubMed Web of Science ®Google Scholar
• Peña-Sagredo JL, Hernández MV, Fernandez-Llanio N, Giménez-Ubeda E, Muñoz-Fernandez S, Ortiz A, Gonzalez-Gay MA, Fariñas MC, Biobadaser Group. Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience. Clin Exp Rheumatol 2008; 26(5):854-9
   PubMed Web of Science ®Google Scholar
• Hernandez-Milian A, Payeras-Cifre A. What is new in listeriosis?. Biomed Res Int 2014; 2014:358051; PMID:24822197; http://dx.doi.org/10.1155/2014/358051
   PubMed Web of Science ®Google Scholar
• Calderon-Gonzalez R, Cilla G, Alkorta M, Perez-Trallero E and Alvarez-Dominguez C. Listeriosis outbreaks and their growth in immune cells. 2015 (manuscript in preparation)
   Google Scholar
• Parrilla-Valero F, Vaque-Rafart J. Study of Listeriosis incidence in Spain. Gan Sanit 2014; 28(1):74-6; http://dx.doi.org/10.1016/j.gaceta.2013.03.004
   PubMed Web of Science ®Google Scholar
• Calderón-González R, Frande-Cabanes E, Bronchalo-Vicente L, Lecea-Cuello MJ, Pareja E, Bosch-Martínez A, Fanarraga ML, Yañez-Díaz S, Carrasco-Marín E, Alvarez-Domínguez C. Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH. Front Cell Infect Microbiol 2014; 4(22):1-11; http://dx.doi.org/10.3389/fcimb.2014.00022
   Web of Science ®Google Scholar
• Calderon-Gonzalez R, Frande-Cabanes E, Tobes R, Pareja E, Alaez-Alvarez L, Alvarez-Dominguez C. A dendritic cell-targeted vaccine loaded with glyceraldehyde-3-phosphate dehydrogenase peptides proposed for individuals at high risk of listeriosis. J Vaccines Vaccin 2015; 6(266):1-8; http://dx.doi.org/10.4172/2157-7560.1000266
   Google Scholar
• Calderon-Gonzalez R, Tobes R, Pareja E, Frande-Cabanes E, Petrovsky N, Alvarez-Dominguez C. Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines. J Immunol Methods 2015 May 29; pii: S0022-1759(15)30002-8; doi:10.1016/j.jim.2015.05.009
   PubMed Web of Science ®Google Scholar
• Pion M, Serramia MJ, Diaz L, Bryszewska M, Gallart T, García F, Gómez R, de la Mata FJ, Muñoz-Fernandez MA. Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer. Biomaterials 2010;31(33):8749-58; PMID:20832111; http://dx.doi.org/10.1016/j.biomaterials.2010.07.093
   PubMed Web of Science ®Google Scholar
• Di Gianvincenzo P, Calvo J, Perez S, Álvarez A, Bedoya LM, Alcamí J, Penadés S. Negatively charged glyconanoparticles modulate and stabilize the secondary structures of a gp120 V3 loop peptide: toward fully synthetic HIV vaccine candidates. Bioconjug Chem 2015; 26(4):755-65; PMID:25734507; http://dx.doi.org/10.1021/acs.bioconjchem.5b00077
   PubMed Web of Science ®Google Scholar
• Safari D, Marradi M, Chiodo F, Dekker HATh, Shan Y, Adamo R, Oscarson S, Rijkers GT, Lahmann M, Kamerling JP, Penadés S, Snippe H. Gold nanoparticles as carriers for a synthetic Streptococcus pneumonia type 14 conjugate vaccine. Nanomedicine 2012; 7: 651-662.
   PubMed Web of Science ®Google Scholar
• Marradi M, Chiodo F, García I, Penadés S. Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem Soc Rev 2013; 42: 4728-4745.
   PubMed Web of Science ®Google Scholar
• de la Fuente JM, Penadés S. Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science. Biochim Biophys Acta 2006; 1760(4):636-51; PMID:16529864; http://dx.doi.org/10.1016/j.bbagen.2005.12.001
   PubMed Web of Science ®Google Scholar
• de la Fuente JM, Barrientos AG, Rojas TC, Rojo J, Cañada J, Fernández A, Penades S. Gold glyconanoparticles as water-soluble polyvalent models to study carbohydrate interactions. Angew Chem Int Ed 2001; 40(12):2257-61; http://dx.doi.org/10.1002/1521-3773(20010618)40:12%3c2257::AID-ANIE2257%3e3.0.CO;2-S
   PubMedGoogle Scholar
• Marradi M, Chiodo F, García I, Penadés S. Glyconanoparticles as multifunctional and multimodal carbohydrate systems. Chem Soc Rev 2013; 42:4728; PMID:23288339; http://dx.doi.org/10.1039/c2cs35420a
   PubMed Web of Science ®Google Scholar
• Rodriguez-Del Rio E, Marradi M, Calderon-Gonzalez R, Frande-Cabanes E, Penadés S, Petrovsky N, Alvarez-Dominguez C. A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection. Vaccine 2015; 33(12):1465-73; PMID:25659269; http://dx.doi.org/10.1016/j.vaccine.2015.01.062
   PubMed Web of Science ®Google Scholar
• Kono M, Nakamura Y, Suda T, Uchijima M, Tsujimura K, Nagata T, Giermasz AS, Kalinski P, Nakamura H, Chida K. Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine. Vaccine 2012; 30:2633-9; PMID:22365841; http://dx.doi.org/10.1016/j.vaccine.2012.02.026
   PubMed Web of Science ®Google Scholar
• Gordon DL, Sajkov D, Woodman RJ, Honda-Okubo Y, Cox MM, Heinzel S, Petrovsky N. Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant. Vaccine 2012; 30(36):5407-16; PMID:22717330; http://dx.doi.org/10.1016/j.vaccine.2012.06.009
   PubMed Web of Science ®Google Scholar
• Gordon D, Kelley P, Heinzel S, Cooper P, Petrovsky N. Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study. Vaccine 2014; 32(48):6469-77 PMID:25267153; http://dx.doi.org/10.1016/j.vaccine.2014.09.034
   PubMed Web of Science ®Google Scholar
• Cristillo AD, Ferrari MG, Hudacik L, Lewis B, Galmin L, Bowen B, Thompson D, Petrovsky N, Markham P, Pal R. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. J Gen Virol 2011; 92(Pt 1):128-40; PMID:21169215; http://dx.doi.org/10.1099/vir.0.023242-0
   PubMed Web of Science ®Google Scholar
• Honda-Okubo Y, Saade F, Petrovsky N. AdvaxTM, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses. Vaccine 2012; 30:5373-81; PMID:22728225; http://dx.doi.org/10.1016/j.vaccine.2012.06.021
   PubMed Web of Science ®Google Scholar